FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
where X is S or O, mor is a morpholine group, and R3 is a monocyclic heteroaryl group, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, which are used to modulate lipid kinase activity, including PI3K, and for treating lipid kinase mediated disorders such as cancer.
EFFECT: obtaining compounds which are used to modulate lipid kinase activity, including PI3K, and for treating lipid kinase mediated disorders such as cancer.
27 cl, 1 tbl, 354 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOINOSITIDE3-KINASE INHIBITING COMPOUNDS AND METHODS FOR USE THEREOF | 2007 |
|
RU2470936C2 |
PHARMACEUTICAL COMPOUNDS | 2007 |
|
RU2443706C2 |
PHARMACEUTICAL COMPOUNDS | 2005 |
|
RU2422449C2 |
PHARMACEUTICAL COMPOUNDS | 2005 |
|
RU2422448C2 |
PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
TRIAZINE, PYRIMIDINE AND PYRIDINE ANALOGUES AND USE THEREOF AS THERAPEUTIC AGENTS AND DIAGNOSTIC SAMPLES | 2009 |
|
RU2537945C2 |
MORPHOLINOPURINE DERIVATIVES, HAVING PI3K AND/OR mTOR INHIBITING ACTIVITY | 2009 |
|
RU2490269C2 |
PURINE COMPOUNDS INHIBITING PI3K, AND APPLICATION METHODS | 2009 |
|
RU2509081C2 |
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID INHIBITORS | 2007 |
|
RU2437888C2 |
POLYCYCLIC SUBSTITUTED PYRAZOLE KINASE ACTIVITY INHIBITORS AND USE THEREOF | 2014 |
|
RU2655921C2 |
Authors
Dates
2012-11-27—Published
2007-12-05—Filed